Tag Archives: Dr Charles Lapp

Estimating prevalence, demographics & costs of ME/CFS using large scale medical claims data & Machine Learning (US)

Estimating prevalence, demographics and costs of ME/CFS using large scale medical claims data and machine learning, by Ashley Valdez, Elizabeth E. Hancock, Seyi Adebayo, David Kiernicki, Daniel Proskauer, John R. Attewell, Lucinda Bateman, Alfred DeMaria, Jr, Charles W. Lapp, Peter … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , , , | Comments Off on Estimating prevalence, demographics & costs of ME/CFS using large scale medical claims data & Machine Learning (US)

Initiating care of a patient with ME/CFS

Initiating care of a patient with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), by Charles W. Lapp in Front. Pediatr., [Published 23 January 2019]   Article abstract: This paper introduces the primary care physician to the unique and challenging aspects of initially … Continue reading

Posted in News | Tagged , , , , , , , | Comments Off on Initiating care of a patient with ME/CFS

Mast Cell Activation may underlie CFS

Medscape blog post, 13 March 2018, by Miriam Tucker: Mast Cell Activation may underlie ‘Chronic Fatigue Syndrome’ Mast cell activation syndrome (MCAS) may be an overlooked yet potentially treatable contributor to the symptoms of chronic fatigue syndrome/myalgic encephalomyelitis (ME/CFS), say … Continue reading

Posted in News | Tagged , , , , , , | Comments Off on Mast Cell Activation may underlie CFS

Nausea and sickness: non-drug options

MEA blog post, 29 June 2016: Dr Charles Shepherd reports on two non-drug options for nausea and sickness in ME/CFS New guidance from the Royal College of Obstetricians and Gynaecologists adds further weight to the fact that two non-drug options … Continue reading

Posted in News | Tagged , , , , | Comments Off on Nausea and sickness: non-drug options

Cognition and ME/CFS

Health Rising’s Cognition Resource hub contains 3 new papers with useful information about cognitive problems in ME. Cognition and Chronic Fatigue Syndrome (ME/CFS): Key Findings and Seminal Papers- The what, where and why of the thinking problems found in ME/CFS, by … Continue reading

Posted in News | Tagged , , , , | Comments Off on Cognition and ME/CFS

US clinician-researchers video talks

ME Research UK report: CDC Grand Round presentation, 23 Feb 2016 The Centers for Disease Control and Prevention (CDC) in the US hosts regular ‘Public Health Grand Rounds’, which focus on particular topics of interest. Last week, the topic was ME/CFS … Continue reading

Posted in News | Tagged , , , , , , | Comments Off on US clinician-researchers video talks

Characteristics of CFS/ME sub-group who respond to Rintatolimod (Ampligen)

Research abstract: Background: Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a debilitating disease of unknown pathogenesis consisting of  a variety of flu-like symptoms including severe fatigue. Initial analysis of the use of rintatolimod (Poly I: Poly C12U), a selective TLR3 agonist, … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , , | Comments Off on Characteristics of CFS/ME sub-group who respond to Rintatolimod (Ampligen)

CFS: The challenges in primary care: a webinar

A new continuing medical education program about CFS has been launched on Medscape as a collaboration between Medscape Education and the CDC, the Centers for Disease Control in the US. The video program features expert physicians Dr Anthony Komaroff, Dr … Continue reading

Posted in News | Tagged , , , , , | Comments Off on CFS: The challenges in primary care: a webinar